Phacomatosis spilosebacea: A new name for a distinctive binary genodermatosis.
Torchia D, Happle R.
J Am Acad Dermatol. 2023 Oct;89(4):764-773. doi: 10.1016/j.jaad.2020.12.082. Epub 2021 Feb 12.
Phacomatosis pigmentovascularis revisited and reclassified.
Happle R.
Arch Dermatol. 2005 Mar;141(3):385-8. doi: 10.1001/archderm.141.3.385.
Phacomatosis spilorosea versus phacomatosis melanorosea: a critical reappraisal of the worldwide literature with updated classification of phacomatosis pigmentovascularis.
Torchia D.
Acta Dermatovenerol Alp Pannonica Adriat. 2021 Mar;30(1):27-30.
Phacomatosis pigmentovascularis.
Fischer K, Trautinger F.
J Dtsch Dermatol Ges. 2015 Nov;13(11):1178-9. doi: 10.1111/ddg.12834.
The risk of glaucoma associated with phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata.
Huang S, Yang Y, Ouyang Z, Guo X, Zhan Z, Liu X, Chen Z, Xu J, Yu M.
Eur J Dermatol. 2022 Sep 1;32(5):589-596. doi: 10.1684/ejd.2022.4317.
Phacomatosis spilosebacea and cutaneous skeletal hypophosphatemia syndrome.
Torchia D.
Bone. 2023 Mar;168:116649. doi: 10.1016/j.bone.2022.116649. Epub 2022 Dec 20.
Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review.
Kumar A, Zastrow DB, Kravets EJ, Beleford D, Ruzhnikov MRZ, Grove ME, Dries AM, Kohler JN, Waggott DM, Yang Y, Huang Y; Undiagnosed Diseases Network; Mackenzie KM, Eng CM, Fisher PG, Ashley EA, Teng JM, Stevenson DA, Shieh JT, Wheeler MT, Bernstein JA.
Am J Med Genet A. 2019 Jun;179(6):966-977. doi: 10.1002/ajmg.a.61134. Epub 2019 Mar 28.
[Phacomatosis].
Valeyrie-Allanore L, Wolkenstein P.
Rev Prat. 2008 Apr 15;58(7):717-24.
Phacomatosis cesioflammea.
Fernández-Guarino M, Boixeda de Miguel P, Jaén Olasolo P.
Dermatology. 2007;214(3):274. doi: 10.1159/000099596.
Phacomatosis pigmentokeratotica.
Hill VA, Felix RH, Mortimer PS, Harper JI.
J R Soc Med. 2003 Jan;96(1):30-1. doi: 10.1177/014107680309600109.
